Unified Patent Court (UPC) analytics are now available. Check here

In the competitive field of Respiratory Drugs, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Respiratory Drugs technology and learn how to protect your intellectual property.

Get Comprehensive Patent Opposition Report for the Respiratory Drugs Industry

Gain strategic insights, uncover critical details, and make informed decisions with expert-backed analysis.

Get Your Report Now

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Respiratory Drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Respiratory Drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Respiratory Drugs industry

EP3897646Pharmaceutical Composition For The Treatment Of Pulmonary Arterial HypertensionACTELION PHARMACEUTICALSFeb 21, 2025SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
EP3897646Pharmaceutical Composition For The Treatment Of Pulmonary Arterial HypertensionACTELION PHARMACEUTICALSFeb 7, 2025SANDOZ
EP3848028Methods Of Treating Ocular ConditionsOYSTER POINT PHARMAFeb 6, 2025HOFFMANN EITLE
EP3335707Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor AgonistGLAXO GROUPJan 17, 2025TEVA UK
EP3973987Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSOct 10, 2024BOULT WADE TENNANT
EP3973987Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYOct 9, 2024SECERNA
EP3973987Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSOct 1, 2024DR H ULRICH DORRIES
EP3703818Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSAug 1, 2024DR H ULRICH DORRIES
EP3703818Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSJul 31, 2024HAMPTON KNOWLES
EP3703818Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYJul 30, 2024BOEHMERT & BOEHMERT ANWALTSPARTNERSCHAFT MBB

To stay ahead in the competitive Respiratory Drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the Respiratory Drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP2228064Dec 11, 2019Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor AgonistNOVARTIS10
EP2400950May 22, 2019Pharmaceutical Formulations Comprising 4-{(1R)-2- [(6-{2-[(2,6-Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2- (Hydroxymethyl)PhenolGLAXO GROUP8
EP3703818Nov 1, 2023Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS7
EP2506850May 13, 2020Methods Of Administering Pirfenidone TherapyINTERMUNE6
EP2637664Mar 29, 2017Compositions And Methods Of Treating Pulmonary HypertensionGILEAD SCIENCES6
EP3973987Jan 10, 2024Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGY6
EP3335707Apr 17, 2024Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor AgonistGLAXO GROUP5
EP2957551Jan 15, 2020Dry Powder Formulations Comprising VilanterolARVEN ILAC SANAYI VE TICARET4
EP2653162May 20, 2020Methods Of Administering Fluvoxamine TherapyINTERMUNE4
EP3053580Jun 30, 2021Method Of Providing Pirfenidone Therapy To A PatientINTERMUNE4